.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Harvard Business School
Healthtrust
Daiichi Sankyo
US Department of Justice
Fish and Richardson
Citi
Accenture
Chubb
Novartis

Generated: July 21, 2017

DrugPatentWatch Database Preview

MUSE Drug Profile

« Back to Dashboard

Which patents cover Muse, and what generic Muse alternatives are available?

Muse is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in MUSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

Summary for Tradename: MUSE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list60
Clinical Trials: see list6
Patent Applications: see list2,094
Drug Prices:see details
DailyMed Link:MUSE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-001Nov 19, 1996RXYesYes► Subscribe► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-004Nov 19, 1996RXYesYes► Subscribe► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-002Nov 19, 1996RXYesYes► Subscribe► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-003Nov 19, 1996RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MUSE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-003Nov 19, 19965,242,391► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-004Nov 19, 19965,886,039► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-001Nov 19, 19965,886,039► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-002Nov 19, 19964,801,587► Subscribe
Mylan Speciality Lp
MUSE
alprostadil
SUPPOSITORY;URETHRAL020700-004Nov 19, 19965,242,391► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Fuji
Cerilliant
Johnson and Johnson
Colorcon
US Department of Justice
Dow
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot